USANA Health Sciences, Inc.
General ticker "USNA" information:
- Sector: Consumer Staples
- Industry: Personal Care Products
- Capitalization: $717.1M
USANA Health Sciences, Inc. does not follow the US Stock Market performance with the rate: -24.8%.
Estimated limits based on current volatility of 2.1%: low 34.08$, high 35.54$
Factors to consider:
- China accounted for 42.7% of revenue in the fiscal year ended 2022-01-01
- US accounted for 9.3% of revenue in the fiscal year ended 2022-01-01
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-30 to 2025-12-29
- 2023-12-30 to 2024-12-29 estimated range: [35.39$, 60.14$]
- 2024-12-29 to 2025-12-29 estimated range: [38.05$, 63.14$]
Financial Metrics affecting the USNA estimates:
- Positive: Non-GAAP EPS, $ of 3.30 > 2.29
- Positive: 9.05 < Operating profit margin, % of 10.11
- Positive: Return on assets ratio (scaled to [-100,100]) of 9.16 > 7.10
- Negative: Industry operating cash flow per share per price (median), % of 3.20 <= 3.85
- Positive: Interest expense per share, $ of 0.01 <= 0.14
- Positive: -0.96 < Investing cash flow per share, $ of -0.62
Short-term USNA quotes
Long-term USNA plot with estimates
Financial data
| YTD | 2022-01-01 | 2022-12-31 | 2023-12-30 |
|---|---|---|---|
| Operating Revenue | $1,186.46MM | $998.60MM | $921.01MM |
| Operating Expenses | $1,016.27MM | $890.99MM | $827.94MM |
| Operating Income | $170.19MM | $107.61MM | $93.07MM |
| Non-Operating Income | $0.45MM | $1.01MM | $9.38MM |
| Interest Expense | $0.06MM | $0.19MM | $0.26MM |
| R&D Expense | $11.11MM | $11.56MM | $11.45MM |
| Income(Loss) | $170.64MM | $108.62MM | $102.45MM |
| Taxes | $54.14MM | $39.27MM | $38.66MM |
| Profit(Loss) | $116.50MM | $69.35MM | $63.79MM |
| Stockholders Equity | $395.12MM | $434.47MM | $497.20MM |
| Inventory | $98.32MM | $67.09MM | $61.45MM |
| Assets | $577.74MM | $596.55MM | $632.76MM |
| Operating Cash Flow | $121.23MM | $103.90MM | $70.64MM |
| Capital expenditure | $12.76MM | $10.40MM | $14.49MM |
| Investing Cash Flow | $-14.19MM | $-12.37MM | $-11.97MM |
| Financing Cash Flow | $-181.41MM | $-30.09MM | $-14.24MM |
| Earnings Per Share* | $5.78 | $3.60 | $3.31 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.